Histosonics, Inc.

Histosonics, Inc. company information, Employees & Contact Information

HistoSonics is a growth phase company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquefy and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels. The company’s new platform delivers personalized, tissue specific treatments with precision and control, and without the undesirable side effects of many of today’s interventional and surgical modalities. HistoSonics is led by a team of experienced domain experts and industry leaders with offices in Ann Arbor, Michigan and Minneapolis, MN.

Company Details

Employees
268
Founded
-
Address
16305 36th Avenue North,
Phone
(612) 351-0361
Email
in****@****ics.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Plymouth, Minnesota
Looking for a particular Histosonics, Inc. employee's phone or email?

Histosonics, Inc. Questions

News

HistoSonics Announces Oversubscribed $250 Million Growth Financing - Business Wire

HistoSonics Announces Oversubscribed $250 Million Growth Financing Business Wire

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors - Yahoo Finance

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors Yahoo Finance

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members - Business Wire India

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members Business Wire India

Michigan Develops Another Unicorn with $2.2B Acquisition of HistoSonics in Ann Arbor - DBusiness Magazine

Michigan Develops Another Unicorn with $2.2B Acquisition of HistoSonics in Ann Arbor DBusiness Magazine

J&J-backed developer of tumour-targeting ‘sonic beam’ HistoSonics fields takeover offers - Financial Times

J&J-backed developer of tumour-targeting ‘sonic beam’ HistoSonics fields takeover offers Financial Times

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors - 뉴스와이어

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors 뉴스와이어

HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation - Business Wire

HistoSonics’ Edison Histotripsy System Gains Great Britain Early Market Access Under Unmet Clinical Needs Authorisation Business Wire

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members - Business Wire

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members Business Wire

HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift - Business Wire

HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift Business Wire

Proximie and HistoSonics Sign U.S. Partnership to Revolutionize Treatment of Liver Tumors - Business Wire

Proximie and HistoSonics Sign U.S. Partnership to Revolutionize Treatment of Liver Tumors Business Wire

HistoSonics Secures First Major Insurance Coverage for Non-Invasive Histotripsy Treatment for Liver Tumors With Blue Cross Blue Shield of Michigan - Business Wire

HistoSonics Secures First Major Insurance Coverage for Non-Invasive Histotripsy Treatment for Liver Tumors With Blue Cross Blue Shield of Michigan Business Wire

HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials - Business Wire

HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials Business Wire

HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial - Business Wire

HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial Business Wire

HistoSonics® Awarded Exclusive Contract with Veterans Affairs for Tumor Destroying Histotripsy Systems - Yahoo Finance

HistoSonics® Awarded Exclusive Contract with Veterans Affairs for Tumor Destroying Histotripsy Systems Yahoo Finance

HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform - Business Wire

HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform Business Wire

HistoSonics™ Partners with Li Ka Shing Foundation to Launch First Histotripsy Programs in Hong Kong - Business Wire

HistoSonics™ Partners with Li Ka Shing Foundation to Launch First Histotripsy Programs in Hong Kong Business Wire

HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials - Business Wire

HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials Business Wire

HistoSonics Announces $100 Million in Financings and New Appointment to its Board of Directors - PR Newswire

HistoSonics Announces $100 Million in Financings and New Appointment to its Board of Directors PR Newswire

FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System - Business Wire

FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System Business Wire

World’s First Patients Treated With Novel Edison® Histotripsy System - Business Wire

World’s First Patients Treated With Novel Edison® Histotripsy System Business Wire

HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy - PR Newswire

HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy PR Newswire

HistoSonics Announces Published Results of Phase I Liver Tumor Trial - PR Newswire

HistoSonics Announces Published Results of Phase I Liver Tumor Trial PR Newswire

HistoSonics Receives FDA "Breakthrough Device Designation" for Novel Sonic Beam Therapy - PR Newswire

HistoSonics Receives FDA "Breakthrough Device Designation" for Novel Sonic Beam Therapy PR Newswire

HistoSonics Announces $40 Million Financing - PR Newswire

HistoSonics Announces $40 Million Financing PR Newswire

HistoSonics Appoints Dr. Joe Amaral to Position of Vice President of Medical Affairs - PR Newswire

HistoSonics Appoints Dr. Joe Amaral to Position of Vice President of Medical Affairs PR Newswire

HistoSonics Expands Leadership Team As It Accelerates Growth - PR Newswire

HistoSonics Expands Leadership Team As It Accelerates Growth PR Newswire

Top Histosonics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant